Publicacións nas que colabora con Felipe Villacampa Aubá (12)

2022

  1. BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up

    European Urology

2020

  1. Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression

    Journal of Urology

2019

  1. CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status

    Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402

  2. Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status

    Scientific Reports, Vol. 9, Núm. 1

  3. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

    Nature Medicine

2017

  1. BMP4 induces M2 macrophage polarization and favors tumor progression in bladder cancer

    Clinical Cancer Research, Vol. 23, Núm. 23, pp. 7388-7399

  2. Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer

    Oncotarget, Vol. 8, Núm. 6, pp. 10531-10542

  3. UroMark—a urinary biomarker assay for the detection of bladder cancer

    Clinical Epigenetics, Vol. 9, Núm. 1

2015

  1. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer

    Oncotarget, Vol. 6, Núm. 39, pp. 42258-42275

  2. Analysis of the polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer

    Clinical Epigenetics, Vol. 7, Núm. 1

  3. PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors

    Molecular Carcinogenesis, Vol. 54, Núm. 7, pp. 566-576

2014

  1. In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer

    Cancer Research, Vol. 74, Núm. 22, pp. 6565-6577